Shattuck Labs logo

Shattuck Labs share price today

(STTK)

Shattuck Labs share price is $1.27 & ₹108.98 as on 7 Jan 2025, 2.30 'hrs' IST

$1.27

-0.07

(-5.22%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Shattuck Labs share price in Dollar and Rupees. Guide to invest in Shattuck Labs stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Shattuck Labs, along with analyst recommendations, forecasts, and comprehensive financials.

Shattuck Labs share price movements

  • Today's Low: $1.25
    Today's High: $1.35

    Day's Volatility :7.41%

  • 52 Weeks Low: $0.94
    52 Weeks High: $11.76

    52 Weeks Volatility :92.01%

Shattuck Labs Returns

PeriodShattuck Labs Inc.Sector (Health Care)Index (Russel 2000)
3 Months
6.35%
-8.4%
0.0%
6 Months
-63.88%
-3.8%
0.0%
1 Year
-85.89%
-0.1%
0.0%
3 Years
-81.97%
2.9%
-19.8%

Shattuck Labs Key Statistics

in dollars & INR

Previous Close
$1.34
Open
$1.34
Today's High
$1.35
Today's Low
$1.25
Market Capitalization
$64.0M
Today's Volume
$223.2K
52 Week High
$11.76
52 Week Low
$0.94
Revenue TTM
$4.1M
EBITDA
$-86.3M
Earnings Per Share (EPS)
$-1.53
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-68.48%

How to invest in Shattuck Labs from India?

It is very easy for Indian residents to invest directly in Shattuck Labs from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Shattuck Labs stock in both Indian Rupees (INR) and US Dollars (USD). Search for Shattuck Labs or STTK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Shattuck Labs or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Shattuck Labs shares which would translate to 0.676 fractional shares of Shattuck Labs as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Shattuck Labs, in just a few clicks!

Returns in Shattuck Labs for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Shattuck Labs investment value today

Current value as on today

₹16,591

Returns

₹83,409

(-83.41%)

Returns from Shattuck Labs Stock

₹86,632 (-86.63%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Shattuck Labs

-9%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Shattuck Labs on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -9% less investors are searching Shattuck Labs in the last 30 days versus the previous period.

Global Institutional Holdings in Shattuck Labs

  • FMR Inc

    15.00%

  • Prosight Management, LP

    11.90%

  • Redmile Group, LLC

    11.76%

  • Adage Capital Partners Gp LLC

    6.07%

  • BlackRock Inc

    5.18%

  • Vanguard Group Inc

    5.03%

Analyst Recommendation on Shattuck Labs

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Shattuck Labs(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Shattuck Labs

What analysts predicted

Downside of 5.51%

Current:

$1.27

Target:

$1.20

Insights on Shattuck Labs

  • Price Movement

    In the last 7 days, STTK stock has moved up by 14.5%
  • Increasing Revenue

    Revenue is up for the last 7 quarters, 57.0K → 2.99M (in $), with an average increase of 43.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -21.55M → -16.67M (in $), with an average increase of 29.3% per quarter
  • STTK vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 107.5%
  • STTK vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 137.5%
  • Price to Sales

    ForSTTK every $1 of sales, investors are willing to pay $15.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Shattuck Labs Financials in INR & Dollars

FY18Y/Y Change
Revenue
$22.4M
-
Net Income
$-7.4M
-
Net Profit Margin
-32.92%
-
FY19Y/Y Change
Revenue
$9.9M
↓ 55.94%
Net Income
$-23.9M
↑ 223.27%
Net Profit Margin
-241.56%
↓ 208.64%
FY20Y/Y Change
Revenue
$9.9M
↑ 0.48%
Net Income
$-35.4M
↑ 48.37%
Net Profit Margin
-356.71%
↓ 115.15%
FY21Y/Y Change
Revenue
$30.0M
↑ 202.16%
Net Income
$-44.3M
↑ 25.15%
Net Profit Margin
-147.75%
↑ 208.96%
FY22Y/Y Change
Revenue
$652.0K
↓ 97.83%
Net Income
$-100.6M
↑ 126.75%
Net Profit Margin
-15.4K%
↓ 15275.72%
FY23Y/Y Change
Revenue
$1.7M
↑ 154.14%
Net Income
$-87.3M
↓ 13.19%
Net Profit Margin
-5.3K%
↑ 10155.03%
Q2 FY23Q/Q Change
Revenue
$200.0K
↑ 250.88%
Net Income
$-21.3M
↑ 7.88%
Net Profit Margin
-10.7K%
↑ 24041.04%
Q3 FY23Q/Q Change
Revenue
$686.0K
↑ 243.0%
Net Income
$-27.5M
↑ 29.02%
Net Profit Margin
-4.0K%
↑ 6658.28%
Q4 FY23Q/Q Change
Revenue
$714.0K
↑ 4.08%
Net Income
$-17.7M
↓ 35.78%
Net Profit Margin
-2.5K%
↑ 1537.55%
Q1 FY24Q/Q Change
Revenue
$1.1M
↑ 56.16%
Net Income
$-18.5M
↑ 4.62%
Net Profit Margin
-1.7K%
↑ 817.62%
Q2 FY24Q/Q Change
Revenue
$1.6M
↑ 44.3%
Net Income
$-21.6M
↑ 16.47%
Net Profit Margin
-1.3K%
↑ 320.08%
Q3 FY24Q/Q Change
Revenue
$3.0M
↑ 86.26%
Net Income
$-16.7M
↓ 22.63%
Net Profit Margin
-556.39%
↑ 783.08%
FY18Y/Y Change
Profit
$22.4M
-
FY19Y/Y Change
Profit
$-19.1M
↓ 185.17%
FY20Y/Y Change
Profit
$9.9M
↓ 151.97%
FY21Y/Y Change
Profit
$28.6M
↑ 188.27%
FY22Y/Y Change
Profit
$652.0K
↓ 97.72%
FY23Y/Y Change
Profit
$-2.4M
↓ 465.8%
Q2 FY23Q/Q Change
Profit
$-917.0K
↓ 12.0%
Q3 FY23Q/Q Change
Profit
$-334.0K
↓ 63.58%
Q4 FY23Q/Q Change
Profit
$-267.0K
↓ 20.06%
Q1 FY24Q/Q Change
Profit
$141.0K
↓ 152.81%
Q2 FY24Q/Q Change
Profit
$-17.6M
↓ 12603.55%
Q3 FY24Q/Q Change
Profit
$3.0M
↓ 117.0%
FY18Y/Y Change
Operating Cash Flow
$-6.9M
-
Investing Cash Flow
$-29.9M
-
Financing Cash Flow
$35.1M
-
FY19Y/Y Change
Operating Cash Flow
$-21.0M
↑ 203.85%
Investing Cash Flow
$-3.6M
↓ 88.0%
Financing Cash Flow
$-64.0K
↓ 100.18%
FY20Y/Y Change
Operating Cash Flow
$-33.7M
↑ 60.47%
Investing Cash Flow
$-146.3M
↑ 3973.55%
Financing Cash Flow
$330.9M
↓ 517078.12%
FY21Y/Y Change
Operating Cash Flow
$-57.1M
↑ 69.69%
Investing Cash Flow
$-10.4M
↓ 92.86%
Financing Cash Flow
$1.9M
↓ 99.42%
FY22Y/Y Change
Operating Cash Flow
$-94.5M
↑ 65.45%
Investing Cash Flow
$49.4M
↓ 573.41%
Financing Cash Flow
$171.0K
↓ 91.14%
Q2 FY23Q/Q Change
Operating Cash Flow
$-18.6M
↓ 29.65%
Investing Cash Flow
$24.4M
↓ 45.85%
Financing Cash Flow
$33.0K
↓ 15.38%

Shattuck Labs Technicals Summary

Sell

Neutral

Buy

Shattuck Labs is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Shattuck Labs Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Shattuck Labs Inc.
7.2%
-63.88%
-85.89%
-81.97%
-93.07%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Shattuck Labs Inc.
NA
NA
NA
-1.45
-0.68
-0.4
NA
3.06
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Shattuck Labs Inc.
Buy
$64.0M
-93.07%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Shattuck Labs

shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. compounds derived from shattuck’s proprietary agonist redirected checkpoint, arc®, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. the company’s lead wholly owned program, sl-172154 (sirpα-fc-cd40l), which is designed to block the cd47 immune checkpoint and simultaneously agonize the cd40 pathway, is being evaluated in a phase 1 trial. a second compound, sl-279252 (pd1-fc-ox40l), is being evaluated in a phase 1 trial in collaboration with takeda pharmaceuticals. additionally, the company is advancing a proprietary gamma delta t cell engager, gadlen™, platform, which is designed to bridge gamma delta t cells to tumor antigens for the treatment of patients with cancer. shattuck has offices in both austin, tex
Organization
Shattuck Labs
Employees
75
CEO
Dr. Taylor H. Schreiber M.D., Ph.D.
Industry
Health Technology

Management People of Shattuck Labs

NameTitle
Dr. Taylor H. Schreiber M.D., Ph.D.
Co-Founder, CEO & Director
Mr. Andrew R. Neill M.B.A.
Chief Financial Officer
Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.
Chief Medical Officer
Dr. Abhinav A. Shukla Ph.D.
Chief Technical Officer
Mr. Conor Richardson CPA
Vice President of Investor Relations
Dr. Stephen Stout J.D., Ph.D.
General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer
Ms. Casi DeYoung
Chief Business Officer
Dr. Thomas Lampkin Pharm.D.
Senior Vice President of Regulatory Affairs
Mr. George Fromm Ph.D.
Co-Chief Scientific Officer
Mr. Suresh de Silva Ph.D.
Co-Chief Scientific Officer

Important FAQs about investing in Shattuck Labs from India :

What is Shattuck Labs share price today?

Shattuck Labs share price today stands at $1.27, Open: $1.34 ; Previous Close: $1.34 ; High: $1.35 ; Low: $1.25 ; 52 Week High: $11.76 ; 52 Week Low: $0.94. The stock opens at $1.34, after a previous close of $1.34. The stock reached a daily high of $1.35 and a low of $1.25, with a 52-week high of $11.76 and a 52-week low of $0.94.

Can Indians buy Shattuck Labs shares?

Yes, Indians can invest in the Shattuck Labs (STTK) from India.

With INDmoney, you can buy Shattuck Labs at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Shattuck Labs at zero transaction cost.

How can I buy Shattuck Labs shares from India?

It is very easy to buy Shattuck Labs from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Shattuck Labs be purchased?

Yes, you can buy fractional shares of Shattuck Labs with INDmoney app.

What are the documents required to start investing in Shattuck Labs stocks?

To start investing in Shattuck Labs, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Shattuck Labs

Today’s highest price of Shattuck Labs (STTK) is $1.35.

Today’s lowest price of Shattuck Labs (STTK) is $1.25.

What is today's market capitalisation of Shattuck Labs

Today's market capitalisation of Shattuck Labs STTK is 64.0M

What is the 52 Week High and Low Range of Shattuck Labs

  • 52 Week High

    $11.76

  • 52 Week Low

    $0.94

What are the historical returns of Shattuck Labs?

  • 1 Month Returns

    7.2%

  • 3 Months Returns

    -63.88%

  • 1 Year Returns

    -85.89%

  • 5 Years Returns

    -93.07%

Who is the Chief Executive Officer (CEO) of Shattuck Labs

Dr. Taylor H. Schreiber M.D., Ph.D. is the current Chief Executive Officer (CEO) of Shattuck Labs.